Opaleye Management Inc. Buys $31.7K of Grace Therapeutics Inc (GRCE) — SEC Form 4, Sep 23, 2026
This filing has been amended.
View the latest version
Open-Market Net Purchase · SEC Form 4
+$31,687
Equity position changed by +0.5%
Equity Position
2.86M sh
2,840,229 → 2,855,318
Equity Change
+0.5%
shares held after vs before
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Opaleye Management Inc. CIK 0001595855 |
10% Owner
|
Opaleye Management Inc. at Grace Therapeutics Inc
Full insider history
Bought (12 mo)
$676,929
Sold (12 mo)
—
More from this insider at Grace Therapeutics Inc
| 2026-11-19 | Buy | +$83,435 | View |
| 2026-11-06 | Buy | +$33,019 | View |
| 2026-10-26 | Buy | +$158,601 | View |
| 2026-10-21 | Buy | +$8,001 | View |
| 2026-10-17 | Buy | +$136,178 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1F2 | 2026-09-21 | P - Purchase | 9,771 A | $2.10 | +$20,519 | 2,850,000 | Indirect By Opaleye, L.P. |
| Common Stock, par value $0.0001 per shareF1F2 | 2026-09-23 | P - Purchase | 5,318 A | $2.10 | +$11,168 | 2,855,318 | Indirect By Opaleye, L.P. |
Footnotes (2)
- F1
- Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund. Show more
- F2
- Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose. Show more
Related filings at Grace Therapeutics Inc
Institutional Holders
13F holders · Sep 30, 2026
38
institutional managers reporting a position
Largest by reported value
- Opaleye Management Inc. $6.02M
- Cerity Partners Llc $1.83M
- Eversept Partners, Lp $1.66M
5%+ Holders · 13D/G
3 filers
Other insiders at Grace Therapeutics Inc
GET /v1/forms/4/0001493152-26-043996
API docs
View Original SEC Filing